Nice Insight
The ex vivo cell and gene therapy medicine field has entered into a new era driven by the registration of the first autologous products, namely Kymriah (Novartis, 2017, U.S.), Yescarta ...
Ryan MacDonald
Avid Bioservices began transitioning to single-use technology (SUT) several years ago and has reaped considerable benefits, both to our operations and to the agile service we provide customers. ...
Frank Mathias, Ph.D.
As a leading CDMO focused on biopharmaceuticals in an increasingly complex global landscape, Rentschler Biopharma SE continues to strategically innovate through a unique go-to-market approach ...
Nice Insight
ENTERPRISE SPONSOR: Equipment Federal Equipment, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Over the next ...
Andrew Boyle
Secure, validated cold-chain transportation is a scarce resource. Trends in the logistics sector and the emergence of the COVID-19 pandemic have created significant bottlenecks in the ...
Nice Insight
ENTERPRISE SPONSOR: EXCIPIENTS SPI Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. The pharmaceutical ...
Haig Armaghanian
The COVID-19 era has, once again, positioned the pharmaceutical industry center stage before a global audience. On the one hand, the industry’s awe-inspiring vaccine development work positions ...
Nice Insight
TECHNOLOGY SPONSOR: Comparator Drug Sourcing Globyz, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Globyz ...
Nice Insight
ENTERPRISE SPONSOR: CRO SanaClis, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Over the coming decade, ...
Pierre Luzeau, Ph.D.
Seqens was formed in December 2018 when Novacap merged with PCI Synthesis, PCAS, Uetikon, and Proteus. With 24 manufacturing plants and three R&D centers in Europe, North America, and Asia, we ...
Nice Insight
TECHNOLOGY SPONSOR: Cleanrooms AES Clean Technology, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Over the ...
Nice Insight
TECHNOLOGY SPONSOR: Semi-Solids TriRx Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. The industry is ...
Daniel Joseph Price
IN CONVERSATION: Daniel Price and Thomas Kipping, Ph.D., discussed MilliporeSigma’s contribution to overcoming solubility challenges with Pharma’s Almanac Scientific Editor-in-Chief David ...
Deborah A. Graham
At Avara, our business is built upon the flexibility and adaptability that comes with centering our efforts around the needs of our clients. We view ourselves as true client partners, with ...
Nice Insight
TECHNOLOGY SPONSOR: Plasma Proteins Evolve Biologics, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Originally ...
Justin Kadis
IN CONVERSATION: Pharma’s Almanac Editor-in-Chief David Alvaro, Ph.D. had a (virtual) conversation with Federal Equipment Company’s Justin Kadis about how the company is using virtual means to ...
Jessica Shea
Single-use technologies provide many benefits; however, they require additional preparative work before being implemented. This includes regulatory approval and assurances that extractables and ...
Nice Insight
TECHNOLOGY SPONSOR: Bioanalytical Services Altis Biosystems, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. ...
Nice Insight
TECHNOLOGY SPONSOR: Venture Capital & Private Equity Dynamk Capital, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma ...
Nice Insight
In these unprecedented times, we are deeply committed to safeguarding the reliable delivery of essential therapeutics for our clients while also remaining dedicated to ensuring the safety of our ...
Aaron Styles
Biopharmaceutical manufacturers can only be competitive if they are nimble and agile — and that includes the design, construction, and operation of manufacturing facilities. With our ...
Morgan Brandt
There is tremendous opportunity to elevate customer experiences and enhance internal operations through digital transformation. At PCI Pharma Services, we embarked on a digital transformation ...
Nice Insight
ENTERPRISE SPONSOR: Microbiome Arranta Bio, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. Increasing evidence ...
Nice Insight
ENTERPRISE SPONSOR: Oral Solid Dose (OSD) Avara, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. As ...
Melanie Cerullo
As a pioneering CDMO innovating solutions in supplying live biotherapeutics, Arranta Bio is at the forefront of some of the most exciting advances in the microbiome space. Since the inception of ...
Nice Insight
ENTERPRISE SPONSOR: Mammalian Biologics Polpharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. If there has ...
Ron Laethem, Ph.D.
Due to a lack of robust in vivo gut models, animal studies are generally required to evaluate gut toxicity. However, these studies can be lengthy and expensive and may not accurately ...
Rose Blackburne, M.D., MBA
To be most successful, dermatology clinical trials should be accessible to a diverse array of qualified patients and designed to encourage patient participation. These trials should also reduce ...
Jyothi Swamy, Ph.D.
The pipeline for antibody–drug conjugates (ADCs) includes hundreds of candidates, with several expected to receive approval in the near future. Outsourcing of development and manufacturing for ...
Tim Tyson
On September 1, 2020, TriRx Pharmaceutical Services, a global CDMO serving the biopharmaceutical market, announced its acquisition of a manufacturing site in Segré, France. The agreement between ...
Graham Brearley, Ph.D.
The COVID-19 pandemic has stretched the limits of pharmaceutical development and manufacturing due to the pressing need for billions of doses to reach patients as soon as possible. It is clear ...
Nice Insight
TECHNOLOGY SPONSOR: Glass SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is envisioning the future of the pharma/biopharma industry. The industry will ...
Our fourth quarter edition features leading insights from subject matter experts covering a range of topics, with a focus on innovations driving the future of healthcare, including solutions to the COVID-19 pandemic. In this issue, leaders from all facets of the pharmaceutical industry discuss their approach to developing and distributing COVID-19 vaccines globally, enabling innovation, facilitating decentralized clinical trials, stem cell technology, and ways to communicate and conduct marketing virtually during the pandemic.
Download Current IssuePharmaBlock Enters Strategic Partnership with Ascentage Pharma
HALIX Signs Agreement With AstraZeneca For Commercial Manufacture Of COVID-19 Vaccine
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory